Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
DELCATH SYSTEMS, INC. | CHIEF MEDICAL OFFICER | Common Stock | 127K | $472K | $3.72 | Mar 19, 2024 | Direct |
AILERON THERAPEUTICS INC | Chief Medical Officer | Stock Option (right to buy) | 150K | Mar 30, 2022 | Direct | ||
DELCATH SYSTEMS, INC. | CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | 101K | Feb 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DCTH | DELCATH SYSTEMS, INC. | Mar 19, 2024 | 1 | $100K | 4 | Mar 19, 2024 | CHIEF MEDICAL OFFICER |
DCTH | DELCATH SYSTEMS, INC. | Feb 12, 2024 | 1 | $0 | 4 | Feb 14, 2024 | CHIEF MEDICAL OFFICER |
DCTH | DELCATH SYSTEMS, INC. | Dec 12, 2023 | 1 | $120K | 4 | Dec 14, 2023 | Chief Medical Officer |
DCTH | DELCATH SYSTEMS, INC. | Nov 16, 2023 | 1 | $149K | 4 | Nov 20, 2023 | Chief Medical Officer |
DCTH | DELCATH SYSTEMS, INC. | Jun 19, 2023 | 0 | $0 | 3 | Jun 22, 2023 | Chief Medical Officer, Exhibit 24 - Power of Attorney |
ALRN | AILERON THERAPEUTICS INC | Mar 30, 2022 | 1 | $0 | 4/A | Mar 30, 2022 | Chief Medical Officer |
ALRN | AILERON THERAPEUTICS INC | Mar 22, 2022 | 1 | $0 | 4 | Mar 24, 2022 | Chief Medical Officer |
ALRN | AILERON THERAPEUTICS INC | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Chief Medical Officer |